O3 Partners Investor

O3 Partners N.V. is a listed General Partner (Listed GP) operating as a private capital platform in the CEE and DACH regions. The Companys core activity is the management and partial ownership of venture capital and private equity funds, fund managers and service providers, generating revenues from management fees, carried interest, and dividends, complemented by its own secondaries and strategic portfolios. Through OXO Labs in Budapest, Catalyst Romania, Neulogy Ventures, and its strategic stake in 3TS Capital Partners, O3 covers the full investment lifecycle from incubation to growth and buyout. This diversified model ensures recurring and scalable income streams, strengthens regional consolidation opportunities, and provides investors with transparent, liquid access to private capital returns.


Invests into

Technology: Computational Drug Design & Virtual Screening
Industry: BioPharma AI
Founded Date: 2020-01-01
Investor Type: Funds of Funds
Headquarters: South Holland,Illinois,United States,North America
Funding Status: private